
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LFST market cap is 2.59B. The company's latest EPS is USD -0.1494 and P/E is -45.05.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 280.6M | 300.44M | 312.33M | 312.72M | 325.48M |
Operating Income | -32.27M | -16.77M | -16.74M | 18k | 1.05M |
Net Income | -44.96M | -21.1M | -23.28M | -5.96M | -7.11M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 377.22M | 667.51M | 859.54M | 1.06B | 1.25B |
Operating Income | -315.3M | -286.35M | -210.17M | -189.13M | -32.44M |
Net Income | -270.91M | -343.95M | -215.56M | -186.26M | -57.44M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.11B | 2.11B | 2.12B | 2.11B | 2.12B |
Total Liabilities | 681.04M | 677.32M | 689.32M | 670.85M | 672.01M |
Total Equity | 1.43B | 1.43B | 1.43B | 1.44B | 1.45B |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 0 | 1.93B | 2.17B | 2.11B | 2.12B |
Total Liabilities | 0 | 382.08M | 655.15M | 681.04M | 672.01M |
Total Equity | 0 | 1.55B | 1.52B | 1.43B | 1.45B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.88M | -21.84M | 22.22M | 44.94M | 107.26M |
Investing | -60.34M | -5.1M | -10.21M | -15.27M | -21.57M |
Financing | 47.43M | -2.43M | -3.86M | -5.89M | -9.95M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | 9.42M | 52.79M | -16.88M | 107.26M |
Investing | N/A | -194.08M | -139.46M | -60.34M | -21.57M |
Financing | N/A | 313.86M | 47.26M | 47.43M | -9.95M |
Market Cap | 2.59B |
Price to Earnings Ratio | -45.05 |
Price to Sales Ratio | 2.07 |
Price to Cash Ratio | 16.74 |
Price to Book Ratio | 1.79 |
Dividend Yield | - |
Shares Outstanding | 384.55M |
Average Volume (1 week) | 2.05M |
Average Volume (1 Month) | 2.27M |
52 Week Change | 5.15% |
52 Week High | 8.61 |
52 Week Low | 4.64 |
Spread (Intraday) | 0.43 (6.03%) |
Company Name | LifeStance Health Group Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.lifestance.com |
Industry | health services (8000) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions